Crunching the numbers for HCM... Refresh in a moment for the full analysis.
HUTCHMED (China) Ltd (HCM)
Healthcare
mixed
$15.24
Updated: 2026-04-13
Financial Strength
50
Mixed
Capital Allocation
40
Weak
Key Findings
+
Strong liquidity — current assets more than 2× current liabilities
−
Debt increasing — total debt up more than 10% year over year
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Add to Watchlist
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.